Indivior Pharmaceuticals, Inc. has submitted an 8-K filing to the SEC. The document is currently unavailable due to maintenance on the SEC website. No specific details regarding the filing are accessible at this time.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.